Hidefumi Kasai1, Yasuhiro Tsuji2, Yoichi Hiraki3, Chika Ogami4, Hideto To5 (1.Certara G.K., 2.University of Toyama, 3.National Hospital Organization Beppu Medical Center, 4.University of Toyama, 5.University of Toyama)
セッション情報
Poster
[P27-1] P27-1: Anti-infective drugs (6): Anti-MRSA and antifungals
2017年9月27日(水) 12:30 〜 13:30 Annex Hall (1F)
Chair: Yasuhiro Tsuji, Japan
Yasuo Takeda1, Erika Watanabe2, Akari Shigemi3, Yasuhiro Umezaki4, Kouyou Nakamura5, Keiichirou Ueno6, Ryuji Ikeda7, Yuta Yokoyama8, Kazuaki Matsumoto9, Kazuro Ikawa10, Norifumi Morikawa11, (1.Kagoshima University, 2.Kagoshima University, 3.Kagoshima University, 4.Kagoshima University, 5.Kagoshima University, 6.Kagoshima University, 7.Kagoshima University, 8.Keio University, 9.Keio University, 10.Hiroshima University, 11.Hiroshima University, )
Yoshimasa Tsuchishita1, Hiroki Harima2, Kimihiro Itoh3, Kazuya Takeda4, Yasuo Fujimura5 (1.Maizuru Kyosai Hosipital, 2.Maizuru Kyosai Hosipital, 3.Maizuru Kyosai Hosipital, 4.Maizuru Kyosai Hosipital, 5.Maizuru Kyosai Hosipital)
[P27-1-4] Estimation of the duration to reach peak arbekacin concentration by Monte Carlo simulation
Kazunori Yamaguchi1, Takeyoshi Abe2, Toshiki Takeuchi3, Masahiro Watanabe4, Koichiro Tsuchiya5, Kazuro Ikawa6, Noriyasu Fukuoka7, Masato Kaji8, Hiroaki Tanaka9, Masato Asakura10, Shinji Kosaka11, Hitoshi Houchi12 (1.Kagawa University Hospital, 2.Japan Community Health Care Organization Ritsurin Hospital, 3.Tokushima University, 4.Shujitsu University, 5.Tokushima University, 6.Hiroshima University, 7.Nihon University, 8.Kagawa University Hospital, 9.Kagawa University Hospital, 10.Kagawa University Hospital, 11.Kagawa University Hospital, 12.Kagawa University Hospital)
Cindy Lau1, Deborah Janet Eldrid Marriott2 (1. St. Vincent's Hospital, 2.St. Vincent's Hospital)
Tetsushu Onita1, Noriyuki Ishihara2, Nobuhiro Nishimura3, Hiroki Tamaki4, Kazuro Ikawa5, Norifumi Morikawa6, Kohji Naora7 (1.Shimane University Hospital, 2.Shimane University Hospital, 3.Shimane University Hospital, 4.Shimane University Hospital, 5.Hiroshima University, 6.Hiroshima University, 7.Shimane University Hospital)
Kenneth Kasper1, Leopoldo Guerrero2, Alejandro Orozco3, Byung Moon4, Johnny Valdez5 (1.ARK Diagnostics Inc., 2.ARK Diagnostics Inc., 3.ARK Diagnostics Inc., 4.ARK Diagnostics Inc., 5.ARK Diagnostics Inc.)
Tomoyuki Yamada1, Ryuji Kato2, Kazutaka Oda3, Kaoru Suzuki4, Yoshio Ijiri5, Toshiyuki Ikemoto6, Masami Nishihara7, Tetsuya Hayashi8, Kazuhiko Tanaka9, Hiroshi Tamai10, Akira Ukimura11, Takahiro Katsumata12 (1.Osaka Medical College Hospital, 2.Osaka University of Pharmaceutical Sciences, 3.Kumamoto University Hospital, 4.Osaka Medical College Hospital, 5.Osaka University of Pharmaceutical Sciences, 6.Osaka Medical College Hospital, 7.Osaka Medical College Hospital, 8.Osaka University of Pharmaceutical Sciences, 9.Shirasagi Hospital, 10.Osaka Medical College, 11.Osaka Medical College Hospital, 12.Osaka Medical College Hospital)
Jie Xing1, Shaohua Chia2, Cao Yuan3, Edwin Zhi Wei Ting4, TzePeng Lim5, SiXuan Tan6, Zhaoqi Zhan7 (1.Shimadzu (Asia Pacific) Pte Ltd., 2.Shimadzu (Asia Pacific) Pte Ltd., 3.Shimadzu (Asia Pacific) Pte Ltd., 4.Shimadzu (Asia Pacific) Pte Ltd., 5.Pharmacy,Singapore General Hospital, 6.Pharmacy,Singapore General Hospital, 7.Shimadzu (Asia Pacific) Pte Ltd.)
Antonio D'Avolio1, Giovanna Fatiguso2, Fabio Favata3, Ilaria Zedda4, Amedeo De Nicolo'5, Giovanni Di Perri6 (1.University of Turin, 2.University of Turin, 3.University of Turin, 4.University of Turin, 5.University of Turin, 6.University of Turin)